Randomized phase 3 study of lenalidomide versus chlorambucil as first-line therapy for older patients with chronic lymphocytic leukemia (the ORIGIN trial)

A. Chanan-Khan, M. Egyed, T. Robak, F. A. Martinelli De Oliveira, M. A. Echeveste, S. Dolan, P. Desjardins, J. Z. Blonski, J. Mei, N. Golany, J. Zhang, J. G. Gribben

Research output: Contribution to journalLetterpeer-review

22 Scopus citations
Original languageEnglish (US)
Pages (from-to)1240-1243
Number of pages4
Issue number5
StatePublished - May 1 2017

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this